Observational Study of Explanted Lung Tissues with Pulmonary Fibrosis
This observational study is looking at lung tissues from people with pulmonary fibrosis (scarring of the lungs) to better understand what causes the condition at a cellular level. Researchers will compare these tissues to lung tissues from people without pulmonary fibrosis. The goal is to assess fibroblasts (cells that create connective tissue) and cytokines (proteins that help cells communicate) that are linked to pulmonary fibrosis. This study is for adults aged 18 and older who are awaiting a lung transplant. The study is currently not recruiting, and its status is unclear.
- Study design
- This is an observational study with a planned enrollment of 90 participants. It is not a treatment study, but rather examines existing tissue.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints, assessing fibroblasts and cytokines, were measured at December 2013.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Explanted Lung Tissues With Pulmonary Fibrosis
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Nickolai Dulin, MD · PRINCIPAL_INVESTIGATOR · University of Chicago
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- assess fibroblasts and cytokines associated with pulmonary fibrosis12/2013